RPC

Radient Pharmaceuticals Corporation

RPC • XASE

Radient Pharmaceuticals Corporation is a publicly traded company trading on XASE, led by CEO Luke A. Sarsfield, with a market cap of $756.7M.

CEOLuke A. Sarsfield
Market Cap$756.7M

Next Earnings

Upcoming earnings announcement for Radient Pharmaceuticals Corporation

Date
Tuesday, May 12, 2026 (in a month)
Timing
Before Market Open (8:14 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
$0.18
Revenue Estimate
$77.0M

Earnings History

Past 1 earnings report for Radient Pharmaceuticals Corporation

DatePeriodEPSEPS SurpriseRevenueRev. SurpriseFiling
Feb 12, 2026Q4 2025
$0.26
—
$81.0M
——

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.